All about the fund UBS Lux Equity Fund Biotech USD P-acc, which stocks or funds the fund owns, and how much the fund owns of each holding.
Details
Security
UBS Lux Equity Fund Biotech USD P-acc
Fee
2,25%
ISIN
LU0069152568
Currency
USD
Holdings
10
Recent performance of UBS Lux Equity Fund Biotech USD:
| 1M | -17.78% |
| 3M | -17.30% |
| YTD | -15.08% |
Find funds with similar holdings as UBS Lux Equity Fund Biotech USD here:
| Security | Fee | ||
|---|---|---|---|
1 |
SEB Bioteknikfond D EUR Lux Utd The fund's holdings match to 60% The fund's fee of 1,69% is 0,56 lower Annual Dividend |
(i) | |
| 2 |
Avanza Healthcare by Samuelsson & Hult The fund's holdings match to 50% The fund's fee of 1,25% is 1 lower |
(i) | |
| 3 |
Swedbank Robur Healthcare A The fund's holdings match to 30% The fund's fee of 1,30% is 0,95 lower |
(i) | |
| 4 | Fidelity Sustainable Healthcare Fund A Euro The fund's holdings match to 30% The fund's fee of 1,50% is 0,75 lower |
(i) | |
The fund UBS Lux Equity Fund Biotech USD P-acc has 14 holdings, with the largest being Regeneron Pharmaceuticals at 10.04%, followed by Vertex at 9.9% and Moderna at 9.21%.
Here are all holdings in UBS Lux Equity Fund Biotech USD:
| # | Security | Share | ||
|---|---|---|---|---|
| 1 | US75886F1075 |
(i) | ||
| 2 | US92532F1003 |
(i) | ||
| 3 | US60770K1079 |
(i) | ||
| 4 | US02043Q1076 |
(i) | ||
| 5 |  |
US00287Y1091 |
(i) | |
| 6 | |
US3755581036 |
(i) | |
| 7 | US0311621009 |
(i) | ||
| 8 | US09075V1026 |
(i) | ||
| 9 | US48576A1007 |
(i) | ||
| 10 | GB00BMVP7Y09 |
(i) | ||
10.2% of the fund's holdings are from USA.
| AbbVie Inc 5.52% |
| Gilead Sciences Inc 4.66% |
The list of fund holdings was last updated on April 13, 2025.
Compare UBS Lux Equity Fund Biotech USD P-acc with other funds to see how the allocation differs.
